• PDF
    lock
    Infographic
    Novartis Financial Results - Q1 2018 Infographic

    This infographic provides an overview of our strategy, key milestones and performance for Q1 2018.

  • PDF
    lock
    Infographic
    Novartis Financial Results - Q2 2018 Infographic

    This infographic provides an overview of our strategy, key milestones and performance for Q2 2018.

  • PDF
    lock
    Infographic
    Novartis Financial Results - Q3 2018 Infographic

    This infographic provides an overview of our strategy, key milestones and performance for Q3 2018.

  • PDF
    lock
    Science & Innovation / Infographic
    An introduction to cell and gene therapy

    Cells are the basic building blocks of all living things, and genes can be found deep within cells. Genes are small sections of DNA that carry genetic information and instructions for making proteins, which help build and maintain the body.

  • PDF
    lock
    Science & Innovation / Infographic
    Cell and gene key focus areas

    At Novartis, we are reimagining medicine to produce breakthroughs and address major unmet needs for patients with devastating diseases, including genetic disorders and certain deadly cancers. These efforts are done in collaboration with scientists, physicians, academia, industry partners, and patients.

  • PDF
    lock
    Science & Innovation / Infographic
    A new era of medicine

    Cell and gene therapies could help reduce or eliminate the need for treatments that need to be taken continuously, often for life

  • PDF
    lock
    Disease Awareness / Infographic
    The Sickle Cell World Assessment Survey (SWAY) results

    The Sickle Cell World Assessment Survey (SWAY) uncovers the impact this disease has on patients and their families.

  • PDF
    lock
    Disease Awareness / Infographic
    Cancer 2030: A growing global crisis

    Cancer 2030: A growing global crisis. This infographic shows the projected cancer cases by region.

  • PDF
    lock
    Disease Awareness / Infographic
    COVID-19 Novartis response

    In the face of a global crisis, Novartis has quickly mobilized R&D capabilities, medicines, clinical trials expertise and philanthropic aid to address the coronavirus pandemic.